Zionsville, IN, United States of America

Larry Arnold Larew

This inventor holds 3 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2006-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Larry Arnold Larew. Retrieved from https://idiyas.com/inventor/larry-arnold-larew

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 33.3

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Larry Arnold Larew: Innovator in Pharmaceutical Formulations

Introduction

Larry Arnold Larew is a notable inventor based in Zionsville, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of echinocandin/carbohydrate complexes. With a total of 3 patents, Larew's work has the potential to impact treatments for fungal infections.

Latest Patents

Larew's latest patents focus on echinocandin/carbohydrate complexes. These complexes are described as having improved thermal stability and water solubility. The patents also detail a process for creating these complexes, along with their applications in pharmaceutical formulations and treatments for fungal infections.

Career Highlights

Larry Larew is currently associated with Eli Lilly and Company, where he continues to innovate in the pharmaceutical sector. His work is instrumental in advancing the effectiveness of treatments for various medical conditions.

Collaborations

Some of Larew's coworkers include Nathaniel Milton and James Lawrence Sabatowski. Their collaborative efforts contribute to the innovative environment at Eli Lilly and Company.

Conclusion

Larry Arnold Larew is a prominent figure in the pharmaceutical industry, with a focus on enhancing drug formulations. His contributions through patents and collaborations are paving the way for improved treatments in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…